Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Horizon Pharma acquisition to be significantly accretive, says Stifel
The Fly on the Wall
Thu, 03/20/14 - 08:42 am
Horizon Pharma
M&A
Vidara
Furiex Diarrhea Drug May Lure Takeover by Salix: Real M&A
Bloomberg
Wed, 03/19/14 - 03:55 pm
Salix
Furiex Pharmaceuticals
M&A
eluxadoline
irritable bowel syndrome
Valeant CEO Seeks Acquisitions in High-Growth Health Care
Bloomberg
Wed, 03/19/14 - 03:47 pm
Valeant Pharmaceuticals
M&A
Mike Pearson
Today’s Top Biotech Stories: Horizon Pharma, Prothena, and Portola Pharmaceuticals
Motley Fool
Wed, 03/19/14 - 12:01 pm
Horizon Pharma
Prothena
Portola Pharmaceuticals
M&A
Vidara
NEOD001
andexanet alfa
Varian to acquire cancer software maker Velocity Medical
Mass Device
Wed, 03/19/14 - 11:42 am
Varian
software
Velocity Medical
M&A
Are Biotech Stocks Located in Ireland Top Buyout Candidates?
Wall St 24/7
Wed, 03/19/14 - 11:29 am
Vidara
Shire
Perrigo
M&A
Jazz Pharmaceuticals
Ireland
Endo Health Solutions
biotech
Amarin
Alkermes
Horizon Pharma to buy privately held Vidara for about $660 mln
Yahoo/Reuters
Wed, 03/19/14 - 09:57 am
Horizon Pharma
Vidara
M&A
Novartis in talks to buy Gamida Cell for up to $600 million: report
First Word Pharma
Tue, 03/18/14 - 08:38 am
Novartis
Gamida Cell
M&A
Ten Top Biotech Merger and Partnership Candidates
Wall St 24/7
Fri, 03/14/14 - 10:53 am
M&A
biotech
Alkermes
Akorn
Auxilium
Cubist Pharmaceuticals
Hospira
Jazz Pharmaceuticals
Medivation
NPS Pharmaceuticals
Salix
United Therapeutics
Quest Diagnostics Has An Improved Outlook After Summit Health Acquisition And $600 Million Refinancing
Seeking Alpha
Thu, 03/13/14 - 10:25 am
Quest Diagnostics
diagnostics
Summit Health
M&A
Grateful Actavis board adds $4M to CEO's deal-related bonus tally. Total: $49M
Fierce Pharma
Wed, 03/12/14 - 07:07 pm
executive pay
Actavis
Warner Chilcott
M&A
Industry report shows bleak 2013 for med tech industry
Fierce Medical Devices
Tue, 03/11/14 - 11:15 am
devices
M&A
R&D
InterMune Rises on Takeover Rumour
Yahoo/Zacks.com
Mon, 03/10/14 - 05:05 pm
M&A
InterMune
Sanofi
Esbriet
Boehringer Ingelheim
Novartis
NanoViricides Inc. Denies Rumor That It Is Being Acquired For $4.5B
Yahoo
Fri, 03/7/14 - 12:10 pm
NanoViricides
M&A
Drugmaker InterMune attracts takeover interest -sources
Yahoo/Reuters
Fri, 03/7/14 - 12:09 pm
InterMune
M&A
Stryker Continues Acquisition Spree but Shares Fall
Yahoo/Zacks.com
Thu, 03/6/14 - 09:39 am
M&A
devices
Stryker
Pivot Medical
Teva Has Appetite for ‘Game-Changing Deals,’ CFO Desheh Says
Bloomberg
Wed, 03/5/14 - 10:12 am
Teva Pharmaceuticals
M&A
Why Would Roche Return to the Antibiotics Market?
Motley Fool
Tue, 03/4/14 - 12:26 pm
Roche
antibiotics
Discuva
R&D
M&A
Will Pharma's Future Be Based On The Carl Icahn Business Model?
Forbes
Tue, 03/4/14 - 08:37 am
Carl Icahn
Actavis
Forest Labs
M&A
Health-Care Deals Make Explosive Start to 2014
Motley Fool
Mon, 03/3/14 - 09:13 pm
Actavis
Forest Labs
JNJ
AstraZeneca
Bristol-Myers Squibb
Aptalis
M&A
Pages
« first
‹ previous
…
209
210
211
212
213
214
215
216
217
…
next ›
last »